Alembic Pharmaceuticals Limited (APLLTD)
₹1,040.4
INR+4.95(+0.48%)
As of December 26, 2024 9:59:00 AMAbout Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited develops, manufactures, and markets pharmaceutical products in India and internationally. The company provides branded specialty medicines in various therapeutic areas, such as cardiology, gynecology, gastrology, ophthalmology, dermatology, nephrology/urology, orthopedics, anti-infective, cold and cough, veterinary, and anti-diabetic; generics formulations in oral solids, oncology oral solids and injectables, general injectables and ophthalmic products, dermatology, and oral suspension; and active pharmaceutical ingredients. It also exports its products. The company was founded in 1907 and is headquartered in Vadodara, India.
RevenueLast 12 months
NA
+NA YoY
Total revenue generated from all business operations over the last 12 months
EBITDALast 12 months
NA
Earnings Before Interest, Taxes, Depreciation, and Amortization - a measure of company's operating performance
Price to Sales RatioTTM
3.38
Compares a company's stock price to its revenues. Lower ratio might indicate an undervalued stock
Operating MarginLast 12 months
10.24
+12.3% quarterly YoY
Operating income as a percentage of revenue, indicating operational efficiency
Market Cap
21484.34 CrINR
Total market value of the company's outstanding shares
Employees
14858
Total number of full-time employees worldwide
CEO
Mr. Chirayu Ramanbhai Amin
Chief Executive Officer of the company